Clinical, Epidemiological and Laboratory Features of Invasive Candida parapsilosis Complex Infections in a Brazilian Pediatric Reference Hospital during the COVID-19 Pandemic
Authors:
- Paulo Henrique PeixotoPPPaulo Henrique Peixoto
- Maria Laína SilvaMSMaria Laína Silva
- Fernando Victor PortelaFPFernando Victor Portela
- Bruno da SilvaBSBruno da Silva
- Edlâny MilanezEMEdlâny Milanez
- Denis de OliveiraDODenis de Oliveira
- Aldaíza RibeiroARAldaíza Ribeiro
- Henrique de AlmeidaHAHenrique de Almeida
- Reginaldo Lima-NetoRLReginaldo Lima-Neto
- Glaucia Morgana GuedesGGGlaucia Morgana Guedes
- Débora Castelo-BrancoDCDébora Castelo-Branco
- Rossana CordeiroRCRossana Cordeiro
Open Access
- 13 August 2023
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 9 (8) , 844
Abstract
The present study aimed to describe the clinical, epidemiological and laboratory characteristics of invasive candidiasis by C. parapsilosis complex (CPC) in a Brazilian tertiary pediatric hospital during the COVID-19 pandemic. Clinical samples were processed in the BACT/ALERT® 3D system or on agar plates. Definitive identification was achieved by MALDI-TOF MS. Antifungal susceptibility was initially analyzed by the VITEK 2 system (AST-YS08 card) and confirmed by the CLSI protocol. Patient data were collected from the medical records using a structured questionnaire. CPC was recovered from 124 patients over an 18-month period, as follows: C. parapsilosis (83.87%), C. orthopsilosis (13.71%) and C. metapsilosis (2.42%). Antifungal resistance was not detected. The age of the patients with invasive CPC infections ranged from C. parapsilosis. C. orthopsilosis infections were significantly more prevalent in patients from critical care units. Invasive infections caused by different pathogens occurred in 75 patients up to 30 days after the recovery of CPC isolates. Overall, 23 (18.55%) patients died within 30 days of CPC diagnosis. Catheter removal and antifungal therapy were important measures to prevent mortality. COVID-19 coinfection was only detected in one patient.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil (408891/2022-0, 306295/2022-9)
This publication has 58 references indexed in Scilit:
- Candida parapsilosis candidaemia in a neonatal unit over 7 years: a case series studyBMJ Open, 2012
- Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with CandidemiaAntimicrobial Agents and Chemotherapy, 2011
- Candida parapsilosis, an Emerging Fungal PathogenClinical Microbiology Reviews, 2008
- A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testingNature Protocols, 2008
- The clinical significance of Candida colonization of respiratory tract secretions in critically ill patientsJournal of Critical Care, 2008
- Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococciAPMIS, 2007
- Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003Journal of Clinical Microbiology, 2006
- Fungemia by yeasts in Brazil: occurrence and phenotypic study of strains isolated at the Public Hospital, Botucatu, São PauloJournal of Medical Mycology, 2005
- Candida parapsilosis: Epidemiology, Pathogenicity, Clinical Manifestations, and Antimicrobial SusceptibilityClinical Infectious Diseases, 1992
- A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related InfectionNew England Journal of Medicine, 1977